Endurant Capital Management’s PetMed Express PETS Stock Holding History

Endurant Capital Management’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-105,895	Closed	-$3.35M	–	68
2020 Q3	$3.35M	Buy	+105,895	New	+$3.5M	0.99%	34
2020 Q2	–	Sell	-9,964	Closed	-$287K	–	70
2020 Q1	$287K	Buy	+9,964	New	+$261K	0.13%	50
2019 Q1	–	Sell	-67,010	Closed	-$1.56M	–	82
2018 Q4	$1.56M	Buy	+67,010	New	+$1.79M	0.82%	30

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Endurant Capital Management's PETS Position: Q4 2020 in Review

Endurant Capital Management sold out of PetMed Express (PETS) in Q4 2020, closing a stake of 105,895 shares — an estimated $3.35M sold.

Endurant Capital Management first reported a position in PETS in Q4 2018 and held it in 3 quarters. The position peaked at $3.35M in Q3 2020. 213 funds tracked by Wall St. Rank hold PETS as of Q4 2020.

Endurant Capital Management reported no remaining PetMed Express position as of Q4 2020 after selling out during the quarter.
Endurant Capital Management sold 105,895 PetMed Express shares in Q4 2020, an estimated $3.35M.
Endurant Capital Management first reported a position in PetMed Express in Q4 2018 and held it in 3 quarters.
Endurant Capital Management's PetMed Express position peaked at $3.35M in Q3 2020.
213 funds tracked by Wall St. Rank held PetMed Express as of Q4 2020.

Based on Endurant Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.